supported by grants from the National Natural Science Foundation of China (81972531, 82373175, 82102775, and 82002466);the Major Scientific and Technological Projects of Guangdong Province (2019B020202002);the Young Talents Program of Sun Yat-sen University Cancer Center (YTP-SYSUCC-0067)
There is currently no effective targeted therapeutic strategy for the treatment of central nervous system acute lymphoblastic leukemia(CNS-ALL).Integrinα6 is considered a potential target for CNS-ALL diagnosis and th...